J9202 – Goserelin acetate implant, per 3.6 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9202
- Long description
- Goserelin acetate implant, per 3.6 mg
- Short description
- Goserelin acetate implant
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 1991
- Last change
- January 1, 1997 – No change
Frequently asked questions
What is HCPCS code J9202?
J9202 is a HCPCS Level II code for goserelin acetate implant, per 3.6 mg.
Does Medicare cover J9202?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9190 – Injection, fluorouracil, 500 mg
- J9191 – Injection, fluorouracil (avyxa), 10 mg
- J9192 – Injection, fluorouracil, 10 mg
- J9196 – Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
- J9198 – Injection, gemcitabine hydrochloride, (infugem), 100 mg
- J9199 – Injection, gemcitabine hydrochloride (infugem), 200 mg
- J9200 – Injection, floxuridine, 500 mg
- J9201 – Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9203 – Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 – Injection, mogamulizumab-kpkc, 1 mg
- J9205 – Injection, irinotecan liposome, 1 mg
- J9206 – Injection, irinotecan, 20 mg
- J9207 – Injection, ixabepilone, 1 mg
- J9208 – Injection, ifosfamide, 1 gram
- J9209 – Injection, mesna, 200 mg
- J9210 – Injection, emapalumab-lzsg, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.